Valproate sodium and Ondansetron drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Valproate sodium and Ondansetron together. This study is created by eHealthMe based on reports of 61 people who take Valproate sodium and Ondansetron from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on valproate sodium and ondansetron (the active ingredients of Valproate sodium and Ondansetron, respectively), and Valproate sodium and Ondansetron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Valproate sodium?

Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. (latest outcomes from Valproate sodium 14,405 users)

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. (latest outcomes from Ondansetron 47,113 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 17, 2019

61 people who take Valproate sodium, Ondansetron are studied.


Number of reports submitted per year:

Valproate sodium and Ondansetron drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Diarrhoea
  2. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  3. Myalgia (muscle pain)
  4. Oral pain
  5. Proctalgia (pain in the rectum)
  6. Pruritus (severe itching of the skin)
  7. Rash
  8. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  9. Venoocclusive liver disease (small veins in the liver are obstructed)
  10. Jugular vein thrombosis (clot in jugular vein)
1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Renal tubular necrosis (death of kidney tubules)
  2. Confusional state
  3. Cytokine storm (over-protective immune response that can actually be fatal)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Delirium (wild excitement)
  6. Body temperature increased
  7. Impetigo (contagious skin infection)
  8. Petechiae (a small red or purple spot caused by bleeding into the skin)
  9. Dermatitis allergic (inflammation of the skin due allergic reaction)
  10. Febrile neutropenia (fever with reduced white blood cells)

Most common drug interactions by gender *:

female:
  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Confusional state
  3. Cellulitis (infection under the skin)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Pyrexia (fever)
  6. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  7. Abscess sterile (abscess not produced by an infection)
  8. Anxiety
  9. Catheter site cellulitis (infection of cells near catheter)
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
male:
  1. Delirium (wild excitement)
  2. Confusional state
  3. Circulatory collapse
  4. Diarrhoea
  5. Dry eye (lack of adequate tears)
  6. Epigastric discomfort
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Hypertension (high blood pressure)
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  10. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Discomfort
  2. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  3. Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue)
  4. Mobility decreased (ability to move is reduced)
  5. Muscle contracture (a permanent shortening of a muscle)
  6. Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
  7. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  8. Pain in extremity
  9. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  10. Skin induration (an abnormally hard spot or area on the skin)
20-29:

n/a

30-39:
  1. Cellulitis (infection under the skin)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Rectal fissure (painful condition in which a cut or tear occurs in the anus)
40-49:
  1. Confusional state
  2. Cytokine storm (over-protective immune response that can actually be fatal)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Delirium (wild excitement)
  5. Body temperature increased
  6. Impetigo (contagious skin infection)
  7. Petechiae (a small red or purple spot caused by bleeding into the skin)
  8. Dermatitis allergic (inflammation of the skin due allergic reaction)
  9. Rash pruritic (redness with itching)
  10. Agitation (state of anxiety or nervous excitement)
50-59:
  1. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  2. Circulatory collapse
  3. Delirium (wild excitement)
  4. Diarrhoea
  5. Dry eye (lack of adequate tears)
  6. Epigastric discomfort
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Hypertension (high blood pressure)
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  10. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
60+:
  1. Cardiac failure acute
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
  4. Confusional state
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  7. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  8. Colorectal cancer metastatic (cancer of colon and rectal spreads to other parts)
  9. Condition
  10. Malignant neoplasm progression (cancer tumour came back)

* Approximation only. Some reports may have incomplete information.


Do you take Valproate sodium and Ondansetron?

You are not alone:




Related publications that referenced our studies

Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Valproate sodium and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Ondansetron and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Valproate sodium and Ondansetron
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Valproate sodium and Ondansetron (7,762 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.